accutane and sex drive

Last updated: June 11, 2026

I’ve sat across from enough people mid-course on isotretinoin to know this question comes up far more often than it gets asked out loud.

Someone notices their interest in sex has dropped, or they’re having trouble with arousal or erections, and they assume it’s stress, or they’re embarrassed to bring it up at a 10-minute derm check. So they say nothing and quietly worry.

This article covers what the research actually shows, what the plausible biological reasons are, how symptoms tend to differ between men and women, and – most importantly – what to do if this is happening to you. This is not a scare piece.

Most people on isotretinoin do not experience significant sexual side effects. But some do, and you deserve straight information about it.

I’ll also walk you through exactly how to raise this with your prescriber, because that conversation is less awkward than you think – and more important than most people realize.

Quick answer: Accutane (isotretinoin) can lower sex drive in both men and women, though this side effect is not universal. It may reduce libido by suppressing androgen activity, decreasing genital sensitivity, and affecting mood. Men sometimes report erectile issues, while women may experience vaginal dryness. These effects often resolve after completing the course.

What the Research Actually Shows About Isotretinoin and Sexual Function

The regulatory record on this is real, even if it’s thin.

In 2017, the UK’s Medicines and Healthcare products Regulatory Agency published a drug safety update after a routine EU review found that some patients taking isotretinoin had reported sexual dysfunction, including erectile dysfunction and decreased libido. That update resulted in updated prescribing guidance.

It didn’t say this is common. It said it’s real enough to document.

A 2024 review published on PubMed took a closer look at studies across the literature and found a potential association between isotretinoin and sexual dysfunction – but was careful to note the association is still under investigation. Causation hasn’t been confirmed. What researchers have is a pattern of reports consistent enough to keep studying.

The data on women is particularly sparse, which is its own problem. A 2024 British Journal of Dermatology study surveyed female patients on isotretinoin and found 27 positive responders reporting sexual side effects after starting treatment. None of those 27 had reported sexual problems before they started. That’s not a coincidence you can easily dismiss.

The NHS guidance tells patients directly to speak to a doctor if they experience erectile dysfunction, low sex drive, or vaginal dryness while on isotretinoin. That’s practical advice, not a warning label buried in fine print.

Where it gets complicated is the gap between “rare” as a regulatory classification and what you find when you read patient forums. Regulatory rarity reflects reported adverse events – a figure that is almost always an undercount. People don’t report.

They stop taking the drug, or they wait and see, or they feel too embarrassed to flag it. The honest read is: this happens more often than the official numbers suggest, but how often exactly is still unclear.

For a broader picture of what else to monitor during a course, the Accutane side effects you should monitor page gives useful context.

How Isotretinoin May Interfere with Libido and Sexual Response

Isotretinoin binds to retinoic acid receptors throughout the body – not just in skin. Several plausible pathways connect that receptor activity to changes in sexual function, though none are fully confirmed in the literature yet.

Retinoic acid receptor activity in hormone-regulating tissue – Isotretinoin’s reach extends beyond sebaceous glands to tissues involved in regulating sex hormones, which may disrupt normal hormonal signaling.
Possible interference with testosterone and DHT metabolism – The 2024 PubMed review flagged this as a plausible mechanism: isotretinoin may alter how the body metabolizes testosterone and dihydrotestosterone, both of which directly influence sex drive in men and women.
Drying effect on mucosal tissue – The same mechanism that shrinks oil glands in skin can reduce secretions in genital mucosal tissue. This produces vaginal dryness and, in men, may reduce penile sensitivity – dampening physical response even when desire is present.
Documented link to depression and mood changes – Both the NHS and the MHRA list depression as a known side effect of isotretinoin. Depression independently suppresses libido, often significantly. This is worth understanding because the fix for mood-driven libido loss looks different from the fix for a direct hormonal one. For more on this, the isotretinoin and depression risk article goes deeper.
Indirect psychological effects – Fatigue, discomfort, or simply feeling unwell during a course can reduce interest in sex without any direct pharmacological mechanism. This is still a real effect – just a different category of cause.
Why the mechanism remains unconfirmed – No controlled trial has isolated exactly how isotretinoin produces sexual side effects in the patients who experience them. The evidence is built from adverse event reports and observational data, not randomized studies with sexual function as a primary endpoint.
Direct vs. indirect matters for management – If your libido dropped because your mood dropped, addressing the mood (with your GP) may help. If it’s a direct tissue effect, that’s a different conversation with your dermatologist – potentially about isotretinoin dosage and how it’s adjusted.

Men vs. Women: How Sexual Side Effects Tend to Present Differently

Sexual side effects from isotretinoin don’t look the same across sexes. Knowing how they tend to present can help you identify what you’re experiencing more quickly – and describe it clearly to your doctor. The BAD Patient Hub notes individual reports of lack of interest in sex, vaginal dryness, and difficulty getting or maintaining an erection in patients on isotretinoin.

The table below compares reported patterns in male and female patients. These are patterns from reported cases and available studies – not guaranteed outcomes.

Feature	Male patients	Female patients
Primary reported symptom	Erectile dysfunction, reduced spontaneous desire	Vaginal dryness, reduced arousal, pain during intercourse
Orgasm changes	Ejaculatory changes, reduced intensity	Decreased orgasm intensity or difficulty reaching orgasm
Shared symptoms	General loss of interest in sex, emotional blunting	General loss of interest in sex, emotional blunting
Typical onset	Often reported around weeks 4-8 of treatment	Variable – some early, some mid-course
Reversibility	Most cases resolve after stopping; rare persistent cases documented	Most cases resolve; persistent cases documented but under-studied
Under-reporting risk	Moderate – stigma around ED	High – female sexual dysfunction historically under-reported in drug trials

The under-reporting issue for women is significant. The 2024 BJD study was one of the first to look at this systematically in female patients. Most earlier data came from adverse event filings, which skew toward whichever symptoms patients feel comfortable reporting – and female sexual dysfunction has historically not been that.

Persistent symptoms after stopping treatment are rare but documented. The pattern has some structural similarity to post-finasteride syndrome – a condition where sexual dysfunction continues long after discontinuing a drug that affects hormonal pathways.

Whether a true equivalent exists for isotretinoin is not yet established in the literature, but the possibility is taken seriously enough that it warrants follow-up if symptoms don’t resolve within a few months of stopping.

One Patient’s Experience Partway Through a 6-Month Course

Case: Sexual Side Effects Mid-Course, Male Patient, 40mg/day

I worked with Jamie (anonymized), a 24-year-old male client who came to me for performance coaching about 10 weeks into a 6-month isotretinoin course at 40mg/day for moderate-to-severe acne. He hadn’t flagged anything to his dermatologist. What he described to me – reduced spontaneous desire, partial erectile dysfunction, and a general emotional flatness he called “just not feeling like myself” – had started around week 6 to 8. He assumed it was work stress and had been quietly hoping it would pass.

I encouraged him to raise it at his next derm appointment using direct clinical language, which he did. His dermatologist kept his dose the same but referred him to his GP to monitor mood over the following 4 weeks. By the end of his 6-month course, his libido had partially returned. At the 3-month post-treatment mark, he reported that sexual function felt close to his baseline. What this case showed me clearly: the 6-8 week window is when I most often hear these concerns from people on isotretinoin, and early disclosure shortens the time spent managing it alone.

When to Tell Your Dermatologist – and What to Actually Say

Most people wait too long to raise sexual side effects – or never raise them at all. The NHS advises patients explicitly to speak to a doctor if they experience these symptoms during treatment. Here’s how to do that without it feeling like a difficult conversation.

Before your appointment, take 5 minutes to write down what you’ve noticed.

Track symptoms with dates and severity before the appointment – Note when you first noticed a change, how consistent it is (every day, intermittent, getting worse), and roughly how significant it feels on a 1-10 scale. Dermatologists work with clinical data. Giving them a pattern – “this started around week 6, it’s been consistent for 3 weeks, severity around 6/10” – is more actionable than “I’ve been feeling off lately.”
Use direct clinical language – Say “libido,” “erectile function,” “vaginal dryness,” “arousal.” Euphemisms slow the conversation and sometimes get logged as something vague. Your dermatologist has heard all of this before. Direct language gets you to the right response faster.
Mention any concurrent mood changes – If you’ve felt flat, low, or less interested in things you normally enjoy alongside the libido change, say that explicitly. Depression and libido loss co-occur frequently on isotretinoin, and your dermatologist needs that full picture to decide whether to involve your GP. The isotretinoin and depression risk page covers what to watch for.
Ask specifically about your options – A dose reduction, a monitored treatment pause, or closer monitoring are all real possibilities. Ask directly: “Is a dose reduction something we should consider?” Knowing your options is part of the isotretinoin treatment overview and shouldn’t be a surprise conversation.
Know when to escalate – If symptoms persist for more than 3 months after you’ve stopped isotretinoin, that’s a red flag. Ask for a referral to an endocrinologist or sexual health specialist at that point. Persistent post-treatment dysfunction is rare but documented, and it requires specialist follow-up – not a wait-and-see approach.

What Patients Ask Most About Accutane and Sex Drive

Do sexual side effects from Accutane go away after you stop taking it?

For most patients, yes – symptoms resolve within weeks to a few months of stopping treatment. A small subset reports effects that persist beyond that window, and this is documented in adverse event literature even if it’s not well characterized in controlled studies.

If you’re 3 months post-treatment and still experiencing significant changes, that warrants a conversation with your GP or a referral rather than continued waiting.

How soon after starting Accutane can libido changes appear?

Reports vary. Some patients notice changes within the first 4 to 6 weeks; others only mid-course around months 2 to 3. There’s no reliable predictive timeline, which makes tracking from the start of treatment genuinely useful – it helps you identify a pattern rather than trying to recall when things changed.

Can hormonal birth control make Accutane’s effect on sex drive worse?

Combined oral contraceptives – which are required for female patients on isotretinoin as pregnancy prevention – can independently reduce libido by elevating sex hormone-binding globulin (SHBG), which lowers free testosterone.

If you’re on both, the two effects may compound, and it becomes difficult to attribute symptoms to one cause. Raising this with both your dermatologist and your GP gives you the clearest picture.

Should I stop Accutane if my sex drive drops?

Don’t stop without talking to your dermatologist first. Abrupt cessation can affect treatment outcomes, and a managed dose reduction or a monitored pause is often a better option than stopping entirely. Stopping without guidance also makes it harder to track whether the symptoms resolve in response to the change – which is information you’ll want.

Accutane and Sex Drive